Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Samantha P. Tippen"'
Autor:
Corinne E. Metzger, Christopher L. Newman, Samantha P. Tippen, Natalie T. Golemme, Neal X. Chen, Sharon M. Moe, Matthew R. Allen
Publikováno v:
Bone Reports, Vol 17, Iss , Pp 101612- (2022)
Cortical porosity develops in chronic kidney disease (CKD) and increases with progressing disease. Cortical porosity is likely a prominent contributor to skeletal fragility/fracture. The degree to which cortical porosity occurs throughout the skeleto
Externí odkaz:
https://doaj.org/article/b6fccd08b3344028be47467544d90ed0
Autor:
Elizabeth A. Swallow, Corinne E. Metzger, Neal X. Chen, Joseph M. Wallace, Samantha P. Tippen, Rachel Kohler, Sharon M. Moe, Matthew R. Allen
Publikováno v:
Bone Reports, Vol 16, Iss , Pp 101174- (2022)
Purpose: Patients with chronic kidney disease (CKD) have high risk of fracture in part due to cortical bone deterioration. The goal of this study was to assess the impact of two different bisphosphonates and dosing regimens on cortical microstructure
Externí odkaz:
https://doaj.org/article/478176b5d8024c828717f335f95c00ea
Autor:
Sang T. Kim, Ajay Sheshadri, Vickie Shannon, Dimitrios P. Kontoyiannis, Hagop Kantarjian, Guillermo Garcia-Manero, Farhad Ravandi, Jin S. Im, Prajwal Boddu, Lara Bashoura, Diwakar D. Balachandran, Scott E. Evans, Saadia Faiz, Wilfredo Ruiz Vazquez, Margarita Divenko, Rohit Mathur, Samantha P. Tippen, Curtis Gumbs, Sattva S. Neelapu, Aung Naing, Linghua Wang, Adi Diab, Andrew Futreal, Roza Nurieva, Naval Daver
Publikováno v:
Frontiers in Immunology, Vol 11 (2021)
Patients with acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) treated with immune checkpoint inhibitors (ICIs) are at risk of pneumonitis as well as pneumonia (combined henceforth as ICI-related pulmonary complications). Little is kno
Externí odkaz:
https://doaj.org/article/dc5a725f54754ba59720d7c06fbd8deb
Autor:
Megan L. Noonan, Erica L. Clinkenbeard, Pu Ni, Elizabeth A. Swallow, Samantha P. Tippen, Rafiou Agoro, Matthew R. Allen, Kenneth E. White
Publikováno v:
Physiological Reports, Vol 8, Iss 11, Pp n/a-n/a (2020)
Abstract Iron‐deficiency anemia is a potent stimulator of the phosphaturic hormone Fibroblast growth factor‐23 (FGF23). Anemia, elevated FGF23, and elevated serum phosphate are significant mortality risk factors for patients with chronic kidney d
Externí odkaz:
https://doaj.org/article/a849825e99d14ceca914f561d29de1be
Autor:
Elizabeth A. Swallow, Corinne E. Metzger, Neal X. Chen, Joseph M. Wallace, Samantha P. Tippen, Rachel Kohler, Sharon M. Moe, Matthew R. Allen
Publikováno v:
Bone reports. 16
Patients with chronic kidney disease (CKD) have high risk of fracture in part due to cortical bone deterioration. The goal of this study was to assess the impact of two different bisphosphonates and dosing regimens on cortical microstructure (porosit
Autor:
Spencer A. Sacks, Matthew R. Allen, Corinne E. Metzger, Elizabeth A. Swallow, Samantha P. Tippen, Joseph M. Wallace
Publikováno v:
Bone
Purpose Chronic kidney disease (CKD) and aging are each independently associated with higher fracture risk. Although CKD is highly prevalent in the aging population, the interaction between these two conditions with respect to bone structure and mech
Reversing cortical porosity: Cortical pore infilling in preclinical models of chronic kidney disease
Autor:
Matthew R. Allen, Elizabeth A. Swallow, Max A. Hammond, Samantha P. Tippen, Neal X. Chen, Sharon M. Moe, Alexander J. Stacy, Corinne E. Metzger
Publikováno v:
Bone
Purpose Chronic kidney disease (CKD) patients have a high incidence of fracture due in part to cortical porosity. The goal of this study was to study cortical pore infilling utilizing two rodent models of progressive CKD. Methods Exp 1: Female C57Bl/
Autor:
Elizabeth A. Swallow, Erica L. Clinkenbeard, Megan L. Noonan, Kenneth E. White, Matthew R. Allen, Rafiou Agoro, Samantha P. Tippen, Pu Ni
Publikováno v:
Physiological Reports, Vol 8, Iss 11, Pp n/a-n/a (2020)
Physiological Reports
Physiological Reports
Iron‐deficiency anemia is a potent stimulator of the phosphaturic hormone Fibroblast growth factor‐23 (FGF23). Anemia, elevated FGF23, and elevated serum phosphate are significant mortality risk factors for patients with chronic kidney disease (C
Autor:
Kenneth E. White, Julia M. Hum, Erica L. Clinkenbeard, Samantha P. Tippen, Rafiou Agoro, Megan L. Noonan, Michael P. Liesen, Pu Ni
Publikováno v:
Journal of the Endocrine Society
The adenine diet is widely used in animal models to produce a tubulointerstitial fibrosis and inflammation that mimics human CKD in many aspects. These include the biochemical manifestations hyperphosphatemia and anemia, as well as endocrine dysfunct
Autor:
Pu Ni, Sharon M. Moe, Corinne E. Metzger, Megan L. Noonan, Kenneth E. White, Neal X. Chen, Matthew Prideaux, Spencer A. Sacks, Matthew R. Allen, Samantha P. Tippen, Gerald J. Atkins, William R. Thompson, Elizabeth A. Swallow
Publikováno v:
Bone
Background During aging, there is a normal and mild loss in kidney function that leads to abnormalities of the kidney-bone metabolic axis. In the setting of increased phosphorus intake, hyperphosphatemia can occur despite increased concentrations of